Abstract
According to experts, the blockchain is very suitable for supply chains, as it streamlines processes and reduces their complexity. Both the pharmaceutical and health sectors can take advantage of their potential since, having different intermediaries, processes can become inefficient on many occasions. Blockchain contributes to bringing order and automation. The pharmaceutical sector has been one of the ones that have obtained the most advantages from this technology. Getting a drug out of the box is a long and expensive process that can take a long time between studies and clinical trials and all the regulations. However, if it is possible to gather all the information needed to complete the process of bringing a new drug to light so that it is available immediately and with all the safety guarantees and improve its management, speed up the process. Therefore, blockchain is the most appropriate technology, although the ability to government bodies to recognize the network's benefits is hampered. This study is focused on determining the level of integration of Blockchain technology in the health sector, and the level of acceptance and contradiction in the adoption of the new technology in the community through the application of the neutrosophic Iadov method.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
